Biomedical Translational Research

Chapter 1. Emerging Technologies : Gateway to Understand Molecular Insight of  Diseases, Newer Drugs, Their Design and Targeting.- Chapter 2. Polypharmacology: New Paradigms in Drug Development.- Chapter 3. Drug Repurposing in Biomedical Research : Benefits and Challenges.- Chapter 4. Computational Methods for Drug Repurposing.- Chapter 5. Genomic Approaches for Drug Repositioning.- Chapter 6. Organ-On-A- Chip: Novel in-Vitro Model For Drug Discovery.- Chapter 7. Precision Radiomolecular Oncology: Challenging the Classical Statistical Evidence Based Medicine.- Chapter 8. Drug Repositioning of the Phenylpiperazine Derivative Naftopidil in Prostate Cancer Treatment.- Chapter 9. Biomarker Based Drug Discovery and Reverse Translational Approach.- Chapter 10. Nanotechnology in Dentistry.- Chapter 11. Nanoparticles a Potential Breakthrough in Counteracting Multidrug-Resistant Bacterial Infections: A Holistic View on Underlying Mechanisms and Antibacterial Properties.- Chapter 12. Emerging Role of Cannabinoid System Modulators in Treatment of Cancer.- Chapter 13. Nanodrugs : A Futuristic Approach for Treating Nephrolithiasis.- Chapter 14. Lipo Dermaceuticals : Technological Transformation.- Chapter 15. The Importance of Drug Dose Adjustment in Elderly Patients with Special Considerations for Patients on Diverse Co-Medications and Antidepressants.- Chapter 16. Role of Microfluidics and Nano Fluidics in Managing CAD.- Chapter 17. Targeted Gene Delivery Through Magnetofection: The New Face of Medicine.- Chapter 18. Qbd-Steered Systematic Development of Drug Delivery Nanoconstructs : Vital Precepts, Retrospect and Prospects.- Chapter 19. Nanoemulsions: A Potential Advanced Nanocarrier Platform for Herbal Drug Delivery.- Chapter 20. Sirna Encapsulated Nanoparticles for Targeting Dorsal Root Ganglion (Drg) in Diabetic Neuropathic Pain.- Chapter 21. EGFR Targeted Quinazoline Clubbed Heterocycles as Anti-Cancer Agents. Chapter 22. Therapeutic Human Monoclonal Antibodies.-

Professor Ranbir Chander Sobti is an Emeritus Professor and Indian National Science Academy (INSA) senior scientist at Punjab University. He is a former Vice-Chancellor of the Panjab University, Chandigarh & Babasaheb Bhimrao Ambedkar University (Central University), Lucknow. He started his career as a cytogeneticist and then moved on to molecular biology, including genomics, to understand the susceptibility and disease process of cancer, COPD, AIDS metabolic syndrome, and kidney diseases. He has also used stem cells and nanoparticles to understand the process of tissue organ development through a designed de-cellularization protocol. He has published more than 300 research articles in the journals of international repute and has also published more than 40 books.